Orchid Pharma (India) Today

Equity ratings for Orchid Pharma Limited are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 28th of August 2021 and ending today, the 27th of September 2021. Click here to learn more.
Orchid Pharma Limited cannot be verified against its exchange. Apparently, Orchid Pharma is not available for investing at the moment. Please verify the symbol is currently traded on Bombay Stock Exchange. If you still believe the symbol you are trying to look up is valid please let us know and we will check it as soon as possible.
Refresh

Orchid Pharma Stock Profile

Orchid Pharma Limited, a pharmaceutical company, engages in the development, manufacture, and marketing of pharmaceutical products worldwide. Orchid Pharma Limited was founded in 1992 and is headquartered in Chennai, India. Orchid Pharma operates under Drug Manufacturers - Major classification in India and is traded on Bombay Stock Exchange. It employs 4455 people.. The public information regarding Orchid Pharma Limited's current market price is not available at this time.
Orchid Pharma is not yet fully synchronised with the market data
Orchid Pharma has some characteristics of a very speculative penny stock
Orchid Pharma has high likelihood to experience some financial distress in the next 2 years
Orchid Pharma has high financial leverage indicating that it may have difficulties to generate enough cash to satisfy its financial obligations
The company has accumulated 20.05 B in total debt with debt to equity ratio (D/E) of 169.4, indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Orchid Pharma Limited has a current ratio of 0.33, indicating that it has a negative working capital and may not be able to pay financial obligations in time and when they become due.
The entity reported the revenue of 6.05 B. Net Loss for the year was (1.79 B) with profit before overhead, payroll, taxes, and interest of 3.1 B.
Legal NameOrchid Pharma Limited
Macroaxis Advice
Unlike general analyst consensus, Macroaxis buy hold or sell recommendation is provided in the context of your current investment horizon and risk tolerance. The advice algorithm takes into account all of Orchid Pharma's available fundamental, technical, and predictive indicators. Your current horizon is 90 days - details
Not RatedUndervalued
Orchid Pharma Limited (ORCHIDPHAR) is traded on Bombay Stock Exchange in India and employs 4,455 people. The company currently falls under 'Mega-Cap' category with current market capitalization of 101.8 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Orchid Pharma's market, we take the total number of its shares issued and multiply it by Orchid Pharma's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and these looking for more risk prefer small-cap and mid-cap equities. Orchid Pharma Limited operates under Healthcare sector and is part of Drug Manufacturers - Major industry. The entity has 408.08 K outstanding shares. Orchid Pharma Limited has accumulated about 1.79 B in cash with 91.81 M of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 20.11.
Check Orchid Pharma Probability Of Bankruptcy

Orchid Stock Against Markets

Picking the right benchmark for Orchid Pharma stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in Orchid Pharma stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for Orchid Pharma is critical whether you are bullish or bearish towards Orchid Pharma Limited at a given time.
Orchid Pharma Limited cannot be verified against its exchange. Apparently, Orchid Pharma is not available for investing at the moment. Please verify the symbol is currently traded on Bombay Stock Exchange. If you still believe the symbol you are trying to look up is valid please let us know and we will check it as soon as possible.
Refresh

Try Other Stock Suggestions

View Currently Related Equities

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Orchid Pharma stock to make a market-neutral strategy. Peer analysis of Orchid Pharma could also be used in its relative valuation, which is a method of valuing Orchid Pharma by comparing valuation metrics with similar companies.
Check out Your Equity Center. Note that the Orchid Pharma Limited information on this page should be used as a complementary analysis to other Orchid Pharma's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Idea Breakdown module to analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes.

Other Tools for Orchid Stock

When running Orchid Pharma Limited price analysis, check to measure Orchid Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Orchid Pharma is operating at the current time. Most of Orchid Pharma's value examination focuses on studying past and present price action to predict the probability of Orchid Pharma's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Orchid Pharma's price. Additionally, you may evaluate how the addition of Orchid Pharma to your portfolios can decrease your overall portfolio volatility.
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Go
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Go
Money Managers
Screen money managers from public funds and ETFs managed around the world
Go
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Go
Watchlist Optimization
Optimize watchlists to build efficient portfolio or rebalance existing positions based on mean-variance optimization algorithm
Go
Shere Portfolio
Track or share privately all of your investments from the convenience of any device
Go
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Go